D-0171-2017 Class III Terminated

Recalled by Teva Pharmaceuticals USA — North Wales, PA

FDA drug recall D-0171-2017 was initiated by Teva Pharmaceuticals USA on Nov 1, 2016 and is designated Class III. Reason for recall: Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing. The recall status is terminated (terminated Feb 6, 2018).

Recall details

Product Type
Drugs
Report Date
Dec 14, 2016
Initiation Date
Nov 1, 2016
Termination Date
Feb 6, 2018
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg, 50 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-210-13.

Reason for recall

Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.

Distribution pattern

Nationwide

Code information

Lot #: 150335, 150336, Exp. 4/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0171-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0171-2017. Report a data issue: hello@regdatalab.com.